Jiangsu Yahong Meditech Co., Ltd.SSE: 688176

Announcement on Expected Loss in Performance for 2025

Jan 31, 2026 · Issued by Jiangsu Yahong Meditech Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jan 31, 2026

On 6ix: 6ix.com/news/announcement-on-expected-loss-in-performance-for-2025-143

Announcement on Expected Loss in Performance for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Jiangsu Yahong Meditech Co., Ltd. on 6ix

Earlier from Jiangsu Yahong Meditech

Announcement on Voluntary Disclosure of Permission Granted by the Australian Authorities for the Initiation of Phase I Clinical Trials of APL-2401Jan 23
Announcement on Using Partial Temporarily Idle Raised Funds for Cash ManagementJan 17
Announcement on Voluntary Disclosure of Completion of 1st Subject Enrollment in Phase 1 Clinical Trial of APL-2401Jan 9
Announcement on Voluntary Disclosure of Acceptance of APLD-2304 for European Medical Device RegistrationDec 22, 2025
Announcement on Voluntary Disclosure of Clinical Trial Applications for APL-2401 Approved by China NMPADec 18, 2025

Later from Jiangsu Yahong Meditech

Announcement on Voluntary Disclosure of Successful Acceptance of the Marketing Authorization Application for APL-1702 by the European Medicines AgencyFeb 28
Announcement on Abnormal Fluctuations in Stock TradingMar 7
Announcement on Resignation of Non-independent DirectorMar 28
Announcement on Requesting the General Meeting to Authorize the Board of Directors to Conduct Issuance of Shares to Specific Objects by Summary ProcedureApr 18
Announcement on Resolutions of the 22nd Meeting of the 2nd Board of DirectorsApr 30

All Jiangsu Yahong Meditech news releases

Follow Jiangsu Yahong Meditech into a list and get an email when it puts out news.

Follow Jiangsu Yahong Meditech